Rectal Cancer Trial On Defunctioning Stoma
Launched by RECTAL CANCER TRIAL ON DEFUNCTIONING STOMA STUDY GROUP · Mar 10, 2008
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
The assumption that a defunctioning loop stoma reduces symptomatic anastomotic leakage from 15% to 7.5%, with a level of statistical significance of 5% and a statistical power of 80%, requires randomization of 220 patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Absence of intraoperative adverse events according to the study protocol and the operating surgeon.
- Exclusion Criteria:
- • Presence of intraoperative adverse events according to the study protocol and the operating surgeon.
About Rectal Cancer Trial On Defunctioning Stoma Study Group
The Defunctioning Stoma Study Group is a dedicated clinical trial sponsor focused on advancing research and improving treatment outcomes for patients with rectal cancer. Through rigorous investigation of the role and effectiveness of defunctioning stomas, the group aims to enhance surgical techniques and postoperative care, ultimately optimizing patient recovery and quality of life. Comprising a multidisciplinary team of experts, the study group is committed to conducting high-quality, evidence-based studies that contribute to the growing body of knowledge in colorectal cancer management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Linköping, , Sweden
Patients applied
Trial Officials
Rune Sjödahl, MD, PhD
Study Chair
Department of Surgery, Linköping University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials